Sort
48,018 grants matching “immunotherapy”
Training Program in Immunology
$511,773Gwendalyn J Randolph · Washington University · T32 · FY2021 · AI
Neurologic Alterations in Alzheimer's Disease
$511,768Bradley T Hyman · Massachusetts General Hospital · R01 · FY2006 · AG
âPharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment responseâ
$511,747Robert C Rostomily · Methodist Hospital Research Institute · R01 · FY2024 · NS
Phosphorylation of TSC2 (S1365) as a novel Regulator of mTORC1 Signaling in T Cells
$511,727Erika L Pearce · Johns Hopkins University · R01 · FY2023 · AI
HVEM pathway regulating FRC function and transplant tolerance
$511,721Reza Abdi · Brigham And Women'S Hospital · P01 · FY2020 · AI
The Role of HBeAg in HBV Persistence
$511,721Haitao Guo · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Predictive Markers in Metastatic Renal Cancer
$511,714Eric J Small · University Of California, San Francisco · R01 · FY2012 · CA
Genesis of Defective Effector Lymphocytes in the Helminth-Coinfected Host
$511,711George S. Yap · Rbhs-New Jersey Medical School · R56 · FY2016 · AI
Regulation of ER-beta Signaling in Carcinogenesis
$511,684Rong Li · George Washington University · R01 · FY2019 · CA
Project 1-Combination Immunotherapy with Radioligned Therapy for Metastatic Prostate Cancer
$511,680Lawrence Fong · University Of California, San Francisco · P50 · FY2024 · CA
Developing whole-body computational phantoms for blood dosimetry to model the impact of radiation on the immune system
$511,615Harald Paganetti · Massachusetts General Hospital · R01 · FY2020 · CA
Cell migration and cell-cell interactions in bone marrow
$511,606Ulrich H Von Andrian · Immune Disease Institute, Inc. · P01 · FY2009 · HL
Bitter taste receptors in oral cancer tumor-associated macrophages
$511,578Ryan Michael Carey · University Of Pennsylvania · R01 · FY2025 · DE
Immune biological differences between Triple Negative Breast Cancer in African American and non-African American women and potential immunotherapy opportunities to improve treatment outcome
$511,570Lajos Pusztai · Yale University · R01 · FY2019 · CA
Customized nanofibers with preferential lung-targeting properties for treating metastatic pulmonary tumors
$511,558Vanessa Bellat · Weill Medical Coll Of Cornell Univ · R37 · FY2023 · CA
Development of Oral Immunotherapy against Clostridioides difficile Transmission
$511,553Yongrong Zhang · University Of Maryland Baltimore · R01 · FY2025 · AI
Targeting replication stress to engage DNA sensing STING pathway derived anti-tumor immunity to improve the therapeutic outcomes in uterine cancer
$511,431Jean Zhao · Dana-Farber Cancer Inst · P01 · FY2024 · CA
Intratumoral Cytokine Immunotherapy Studies in Companion Canine Cancer Models
$511,429Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2025 · CA
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.
$511,394Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
CD19 Directed CAR Therapy
$511,366Carl H. June · University Of Pennsylvania · R01 · FY2012 · CA
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$511,345Albert Folch · University Of Washington · R01 · FY2024 · CA
Targeted Therapies for Lymphoid Malignancies
$511,329Jennifer A. Woyach · Ohio State University · R01 · FY2024 · CA
PHASE I/II TRIAL OF HOKT3(1(ALA-ALA) IN TYPE 1 DIABETES
$511,279Columbia University Health Sciences · R01 · FY2002 · DK
Metabolic barriers to T cell activation in clear cell renal cell carcinoma
$511,194Jeffrey C Rathmell · Vanderbilt University Medical Center · R01 · FY2024 · CA
Project-003
$511,159Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2019 · CA